A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)

Amit M. Oza, I. Vergote, Laura Gilbert, Lucy, Prafull Ghatage, A. Lisyankaya, Sharad Ghamande, Suzanne K. Chambers, José Ángel Arranz, Diane Provencher,

Gynecologic Oncology · 2015 · 36 citations · 0 references

Concepts